Member Info for Spikeyj

https://www.fiercepharma.com/pharma/astrazeneca-ceo-cant-be-sure-covid-shot-vaxzevrias-future-company-weighs-wider-split

apologies, wrong board.

https://www.fiercepharma.com/pharma/astrazeneca-ceo-cant-be-sure-covid-shot-vaxzevrias-future-company-weighs-wider-split

(doesn’t bode well for the 18th lifting, if they ever do one.)

link to the whole tempus article in the times:

https://www.thetimes.co.uk/article/insurer-legal-amp-general-on-target-in-capital-shootout-7kqwqpl92?shareToken=d9c198843846c0871a8b7ea8b3796b4a

TDAD19, maybe just try reading back a bit? - that’s a bit of a lazy question, as
i’ve been asked that before, & i’ve answered that before. no, of course i don’t
own any shares in this useless farrago, nor have i ever owned any shares in it.

this is a board for chat about CTAG, its shares & related business.
i‘d be happy to read anything you might have to say about those.

i thought it was mildly interesting that the 17th lifting was so small.

the 15th and 16th liftings combined totalled more than 457,000
barrels of oil, but the 17th lifting was only just over 94,000 barrels.

full year results RNS’d in june mentioned;

“The £2.7 million owed to the Aje JV…”

& bought a few of that 1/7th back.

https://www.ft.com/content/b624eaa8-1caf-4ca9-9fad-17827779281a

joking aside tommy, in all seriousness i would suggest that you should
be *very* wary indeed [translation: run a mile!] if amit makes any kind
of suggestion that you might need to pay some kind of ‘transfer’ /
‘administration’ / ‘legal’ fee etc. to receive any supposed payment.

tommy, in situations like this the payouts are usually
couried direct to shareholders by express flying pig.

still nothing frobert?

i think the reason frobert doesn’t post what the positive
features of ADME are, is just because there aren’t any.

you’d think that a chatboard like this would be busy with
all the long holders and rampers busy trying to talk the
share up, and praise all the positive features. but no, the
ADME board is deathly quiet… the nearest they have to
a cheerleader here is dan (who is pretty mild-mannered).

fair point, i probably didn’t phrase that well, but i think my
meaning was fairly obvious… i.e. it would have been a much
more impressive buy recommendation from tempus if they had
made it *before* the results, rather than after a 12% s/price rise.

hello frobert. still waiting for you to explain the positive things that
make you think ADME is worth investing in. c’mon, don’t be so shy!

hi dan, no, i don’t think the project level debt has
cleared ( - if it had, don’t you think they would have
been shouting it from the rooftops via RNS??)

i think they are just trying not to mention it.

funny how they don’t mention the project level debt in the RNS.

it’s almost like they are hoping pis will forget it if they don’t
mention it. but they still have zero cash, high cashburn, &
now owe a lot of deferred pay and perks to the BOD imv.

placing ahoy!

from thursday … but would have been a bit
more impressive if they’d written it on weds …

https://www.thetimes.co.uk/article/investors-are-to-cash-in-on-avivas-advance-f3frm5xj5?shareToken=e931f87227f416b47d4ec0d988ebc93b

watch for cevian’s next move.

[i think PRC will be a *very* unforgiving environment for political missteps by
large international companies for many years to come …not for the squeamish!]